should i start with semaglutide or tirzepatide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Semaglutide vs. Tirzepatide: Which GLP-1

The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss

By utilizing fats for energy production, this supplement helps conserve glycogen and delay the buildup of lactic acid, which in turn reduces muscle fatigue and extends the horse's ability to perform at peak levels

This mechanism of action has proven effective in promoting weight loss, as demonstrated by clinical trials and real-world use since its approval

Wax B, Kerksick CM, Jagim AR, Mayo JJ, Lyons BC, Kreider RB

Preparing for your Phoenix peptide therapy journey Maximize your results by preparing appropriately before beginning peptide therapy

Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone